|Bid||0.0150 x 0|
|Ask||0.0200 x 0|
|Day's Range||0.0150 - 0.0150|
|52 Week Range||0.0150 - 0.1200|
|Beta (5Y Monthly)||3.35|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
VANCOUVER, BC / ACCESSWIRE / December 2, 2021 / The Power Play by The Market Herald has announced the release of new interviews with Lumiera, FSD Pharma, HydroGraph, and Adastra Holdings discussing their latest press releases.The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.
Lumiera Health Inc. (TSXV: NHP) (the "Company" or "Lumiera "), a company specializing in the development and commercialization of natural health products, is pleased to provide an update to announce that the new corporate strategy and plans that were put in place Q1-Q3 2021 have been successful. Lumiera's fiscal Q4 was a record quarter with sales +30% vs Q4 2020, highlighted by November which was a record sale month, +59.3% over November 2020.
Lumiera Health Inc. (TSXV: NHP) (the "Company" or "Lumiera "), a company specializing in the development and commercialization of natural health products, is pleased to announce that Louis Doyle has been appointed to the Board of Directors of the Company following the resignation of Nathalie Nasseri as a director of the Company.